A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors.
| Autor: | Stuurman FE; Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. r.stuurman@nki.nl, Lolkema MP, Huitema AD, Soetekouw PM, Rosing H, Rolfe L, Kaur P, Beijnen JH, van Tinteren H, Voest EE, Schellens JH |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of clinical pharmacology [J Clin Pharmacol] 2013 Aug; Vol. 53 (8), pp. 878-83. Date of Electronic Publication: 2013 Jun 18. |
| DOI: | 10.1002/jcph.108 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Plný text